Vivo Bio Tech Limited (BOM:511509)

Vivo Bio Tech Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Net Income	-	25.26	26.49	22.02	56.82	44.42
Depreciation & Amortization	-	71.98	71.68	59.32	46.9	51.72
Other Amortization	-	20.93	20.97	15.14	9.02	-
Other Operating Activities	-	62.53	62.84	28.11	-	-
Change in Accounts Receivable	-	-154.26	-61.55	12.51	15.33	-28.48
Change in Accounts Payable	-	128.78	27.9	29.32	13.69	18.43
Operating Cash Flow	-	155.22	148.34	166.42	141.76	86.07
Operating Cash Flow Growth	-	4.64%	-10.87%	17.40%	64.69%	-
Capital Expenditures	-	-79.5	-39.98	-511.12	-228.22	-102.34
Investing Cash Flow	-	-79.5	-39.98	-511.12	-228.22	-102.34
Long-Term Debt Issued	-	-	-	354.29	49.62	7.83
Long-Term Debt Repaid	-	-13.04	-69.87	-	-	-
Net Debt Issued (Repaid)	-	-13.04	-69.87	354.29	49.62	7.83
Issuance of Common Stock	-	-	27.86	31.37	38.21	13.1
Other Financing Activities	-	-62.53	-69.74	-35.48	-	-
Financing Cash Flow	-	-75.57	-111.75	350.18	87.83	20.93
Miscellaneous Cash Flow Adjustments	-	-	-	0	-	-
Net Cash Flow	-	0.15	-3.39	5.48	1.37	4.66
Free Cash Flow	-	75.72	108.36	-344.7	-86.46	-16.27
Free Cash Flow Growth	-	-30.12%	-	-	-	-
Free Cash Flow Margin	-	16.66%	20.75%	-67.07%	-16.70%	-2.94%
Free Cash Flow Per Share	-	4.54	7.31	-24.34	-6.38	-1.26
Cash Interest Paid	-	77.78	76.51	39.93	35.3	30.98
Cash Income Tax Paid	-	15.34	19.72	22.71	29.37	-1.88
Levered Free Cash Flow	-	-105.99	18.8	-390.38	-122.77	-39.47
Unlevered Free Cash Flow	-	-57.37	66.62	-365.42	-100.71	-21.91
Change in Net Working Capital	-	144.53	62.54	-18.94	3.85	16.9

Updated Jan 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.